Ross Portaro
Ventas & Marketing en VENUS CONCEPT INC. .
Fortuna: 6 868 $ al 30/04/2024
Cargos activos de Ross Portaro
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VENUS CONCEPT INC. | Ventas & Marketing | 15/10/2021 | - |
Corporate Officer/Principal | 01/05/2021 | 15/10/2021 |
Historial de carrera de Ross Portaro
Antiguos cargos conocidos de Ross Portaro.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TREX WIND-DOWN, INC. | Ventas & Marketing | 01/01/2014 | 01/01/2016 |
Coherent Medical Group
Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Corporate Officer/Principal | - | - |
CUTERA, INC. | Ventas & Marketing | - | - |
Formación de Ross Portaro.
McIntire School of Commerce | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CUTERA, INC. | Health Technology |
VENUS CONCEPT INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Coherent Medical Group
Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Health Technology |
BioPharmX Corp.
BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ross Portaro
- Experiencia